MEDVis program incorporates pre-treatment evaluations to identify contraindications and assess baseline health markers
TIIDM is primarily found in middle-aged and elderly individuals
Emerging evidence also supports its expanding role in the management of non-alcoholic fatty liver disease (NAFLD), heart failure, polycystic ovary syndrome (PCOS), obstructive sleep apnea (OSA), alcohol use disorder (AUD), and Alzheimers disease
Insert the needle through the rubber stopper of the semaglutide vial at a slight angle
Patients were randomized 1:1 to receive subcutaneous semaglutide 2.4 mg once weekly or placebo as an adjunct to standard-of-care therapy for CVD, such as cholesterol-modifying medications, antiplatelet therapies and antihypertensive agents
Subcutaneous injection bypasses your digestive system entirely